v3.20.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Aug. 31, 2020
Aug. 31, 2019
Operating expenses:    
General and administrative $ 9,875 $ 3,046
Research and development 15,188 9,055
Amortization and depreciation 505 531
Total operating expenses 25,568 12,632
Operating loss (25,568) (12,632)
Other income (expense):    
Change in fair value of derivative liabilities 625
Interest expense:    
Finance charges (10) (8)
Amortization of discount on convertible notes (1,339) (1,030)
Amortization of debt issuance costs (4) (284)
Inducement interest - warrant exercises and debt conversion (3,345) (2,431)
Interest on convertible notes payable (566) (404)
Total interest expense (5,264) (4,157)
Loss before income taxes (30,832) (16,164)
Income tax benefit
Net loss $ (30,832) $ (16,164)
Basic and diluted loss per share $ (0.06) $ (0.04)
Basic and diluted weighted average common shares outstanding 555,531 364,639

Source